TORONTO, May 15 /CNW/ - Microbix Biosystems Inc. (TSX:MBX) today announced its second quarter results for fiscal 2007 and provided an update on the development of its large-market products. “We made significant progress during the quarter in moving all three of our proprietary biotechnology products closer to commercialization,” said William J. Gastle, Chairman and CEO.
